SSH Sunshine Heart INC

CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19

CHF Solutions Announces Data Demonstrating Benefit of Aquadex Therapy for Treatment of Heart Failure and COVID-19
EN
07/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sunshine Heart INC

 PRESS RELEASE

American Medical Association Issues New CPT Code for Nuwellis’ Aquadex...

American Medical Association Issues New CPT Code for Nuwellis’ Aquadex Ultrafiltration The newly classified code expands access to life-saving, novel fluid removal technology EDEN PRAIRIE, Minn., July 13, 2021 (GLOBE NEWSWIRE) -- In an effort to increase the availability of life-saving ultrafiltration therapy to people experiencing fluid overload, the American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT®) code, 0692T for Therapeutic Ultrafiltration. The new CPT code will come into effect on January 1, 2022, at which time providers can util...

 PRESS RELEASE

Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare...

Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference EDEN PRAIRIE, Minn., July 06, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that, Nestor Jaramillo, Chief Executive officer, and George Montague, Chief Financial Officer, are scheduled to participate in the 2021 Ladenburg Thalmann Healthcare Conference on Wednesday, July 14th, 2021. Event:2021 Ladenburg Thalmann Healthcare Conference  Format:Presentation & Fireside Chat  Date:Wednesday, July 14, 202...

 PRESS RELEASE

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 563...

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) EDEN PRAIRIE, Minn., July 01, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 30, 2021, the Compensation Committee of the Board of Directors approved an equity award to George Montague under Nuwellis’ 2021 Inducement Plan, as a material inducement to Mr. Montague entering into employment with the company as its Chief Financial Officer and Treasurer. The equity award was approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announceme...

 PRESS RELEASE

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 563...

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 22, 2021, the independent directors approved four equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to four individuals entering into employment with the company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan. I...

 PRESS RELEASE

Nuwellis Announces New Appointments to Leadership Team

Nuwellis Announces New Appointments to Leadership Team George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn., June 22, 2021 (GLOBE NEWSWIRE) -- Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., today announced the appointment of George Montague as Chief Financial Officer, effective June 28, 2021. Neil ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch